TSS:Hg 47512.1

Basic information about the TSS

---

TSS ID: hg_47512.1 Species: human Chr: chr4		Start: 41990496 End: 41990544 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000513699.5 ENST00000510460.1 ENST00000264451.12 AK312838 BC016949 AK299917 AF006621 Distance: 0 GeneID: 10463 HGNC/MGI_ID: HGNC:1329 UniProt_ID: A0A0S2Z514 B2R745 B4DSU2 D6R9M6 Q6PML9

Gene_name: solute carrier family 30 member 9 Gene_symbol: SLC30A9 Gene_synonyms: GAC63 HUEL ZNT9 Gene_source: HGNC:1329

TATA-Box annotation

---

Distance to TSS:	-10
Nearest PromoterID:	NM_006345
Entrez ID:	10463
Nearest Unigene:	Hs.479634
Nearest Refseq:	NM_006345
Nearest Ensembl:	ENSG00000014824
Gene Name:	solute carrier family 30 member 9
Gene Alias:	BILAPES|C4orf1|GAC63|HUEL|ZNT9
Gene Description:	solute carrier family 30 member 9
Gene Type:	protein-coding
CpG%:	0.095
GC%:	0.621891
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SLC30A9 p2@SLC30A9
Sample		p1@SLC30A9	p2@SLC30A9
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	31.36	2.92
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	36.21	4.05
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	38.97	2.70
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	31.60	4.57
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	27.90	2.92
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	33.34	3.49
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	54.25	5.01
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	41.42	5.33
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	38.47	3.63
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	52.17	4.06
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	42.04	7.68
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	47.16	6.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	56.90	2.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	46.91	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	50.94	2.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	44.77	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	43.03	2.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	45.56	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	45.32	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	45.13	1.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	50.12	2.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	42.98	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	46.27	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	50.72	1.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	44.37	1.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	48.74	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	57.69	2.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	49.51	4.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	48.78	2.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	53.75	2.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	48.57	2.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	53.53	2.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	50.65	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	59.38	2.14
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	50.67	1.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	42.92	1.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	51.30	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	41.10	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	59.15	2.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	53.77	3.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	50.35	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	56.95	2.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	51.46	4.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	55.07	2.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	58.63	3.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	52.58	4.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	46.54	2.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	58.12	3.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	45.24	3.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	46.51	2.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	52.88	3.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	63.82	2.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	335.81	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	51.45	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	50.70	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	171.98	5.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	73.48	2.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	44.08	3.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	45.61	3.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	76.07	4.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	48.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	47.11	2.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	94.74	3.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	55.72	3.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	48.41	3.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	42.60	3.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	339.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	379.08	15.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	48.26	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	49.09	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	48.32	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	63.92	2.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	42.69	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	46.78	0.61
Adipocyte - breast, donor1	11376-118A8	62.72	2.38
Adipocyte - breast, donor2	11327-117E4	42.03	0.80
Adipocyte - omental, donor1	11473-119C6	66.29	2.67
Adipocyte - omental, donor2	11474-119C7	30.65	1.49
Adipocyte - omental, donor3	11475-119C8	33.49	0.67
Adipocyte - perirenal, donor1	11476-119C9	40.19	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	11.00	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	24.84	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	22.42	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	60.24	2.15
Adipocyte differentiation, day04, donor2	13022-139D7	45.30	2.32
Adipocyte differentiation, day04, donor3	13025-139E1	52.69	1.39
Adipocyte differentiation, day04, donor4	13028-139E4	38.80	2.35
Adipocyte differentiation, day08, donor1	13020-139D5	76.41	2.57
Adipocyte differentiation, day08, donor2	13023-139D8	44.86	2.26
Adipocyte differentiation, day08, donor3	13026-139E2	40.52	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	49.52	1.67
Adipocyte differentiation, day12, donor1	13021-139D6	49.08	1.66
Adipocyte differentiation, day12, donor2	13024-139D9	41.94	2.51
Adipocyte differentiation, day12, donor3	13027-139E3	40.25	1.96
Adipocyte differentiation, day12, donor4	13030-139E6	39.58	1.22
Alveolar Epithelial Cells, donor1	11510-119G7	17.02	0.88
Alveolar Epithelial Cells, donor2	11590-120G6	5.74	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	2.40	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	21.77	0.54
Amniotic Epithelial Cells, donor2	11613-122A2	3.35	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	14.18	0.62
Anulus Pulposus Cell, donor1	11248-116E6	68.31	1.60
Anulus Pulposus Cell, donor2	11463-119B5	39.67	1.47
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	37.29	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	50.36	1.74
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	47.09	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	43.94	2.09
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	46.79	2.53
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	34.98	1.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	40.94	1.95
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	49.03	1.94
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	33.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	43.69	1.51
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	41.36	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	35.11	3.76
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	54.20	1.48
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	40.94	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	42.37	1.66
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	47.15	2.14
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	38.54	1.32
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	39.29	1.87
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	42.92	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	37.98	1.16
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	37.22	2.40
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	49.56	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	39.11	1.72
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	29.36	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	50.00	0.97
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	33.01	1.90
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	37.55	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	51.87	1.71
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	40.19	1.07
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	33.55	1.03
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	41.76	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	37.94	1.61
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	26.40	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	40.95	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	40.64	2.11
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	32.08	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	37.12	2.03
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	48.39	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	31.13	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	37.54	1.29
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	31.33	2.75
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	32.77	1.45
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	53.85	1.89
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	35.09	1.86
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	37.06	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	73.94	4.23
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	33.66	2.14
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	35.50	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	48.84	4.37
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	42.76	2.76
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	40.80	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	49.58	2.03
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	35.09	2.48
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	35.50	1.84
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	52.10	2.87
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	43.90	1.77
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	32.04	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	44.31	3.88
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	36.54	1.06
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	28.35	2.18
Astrocyte - cerebellum, donor1	11500-119F6	31.44	1.47
Astrocyte - cerebellum, donor2	11580-120F5	16.09	0.68
Astrocyte - cerebellum, donor3	11661-122F5	8.81	0.63
Astrocyte - cerebral cortex, donor1	11235-116D2	93.77	4.88
Astrocyte - cerebral cortex, donor2	11316-117D2	90.76	4.37
Astrocyte - cerebral cortex, donor3	11392-118C6	78.31	3.73
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	68.58	1.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	63.64	2.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	64.41	1.02
Basophils, donor1	12241-129G9	26.94	6.80
Basophils, donor2	12242-129H1	55.92	5.41
Basophils, donor3	12243-129H2	36.46	3.53
Bronchial Epithelial Cell, donor1	11511-119G8	12.72	0.43
Bronchial Epithelial Cell, donor2	11591-120G7	7.31	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	57.39	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	24.48	1.88
Bronchial Epithelial Cell, donor5	11457-119A8	12.27	0.62
Bronchial Epithelial Cell, donor6	11461-119B3	22.34	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	36.35	1.62
Burkitt's lymphoma cell line:DAUDI	10422-106C8	79.35	3.19
Burkitt's lymphoma cell line:RAJI	10476-106I8	125.30	3.26
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	81.22	2.24
CD133+ stem cells - cord blood derived, pool1	12223-129E9	134.45	0.00
CD14+ Monocytes, donor1	11224-116B9	52.41	10.14
CD14+ Monocytes, donor2	11305-117B9	37.86	3.53
CD14+ Monocytes, donor3	11381-118B4	41.05	4.39
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	72.74	3.11
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	80.74	2.27
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	79.23	1.97
CD14+ monocytes - mock treated, donor1	11863-125A9	36.57	3.18
CD14+ monocytes - mock treated, donor2	11873-125C1	35.00	3.62
CD14+ monocytes - mock treated, donor3	11883-125D2	38.61	6.16
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	34.32	5.02
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	30.91	3.86
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	35.21	4.96
CD14+ monocytes - treated with BCG, donor1	11860-125A6	36.22	2.55
CD14+ monocytes - treated with BCG, donor2	11870-125B7	33.47	4.63
CD14+ monocytes - treated with BCG, donor3	11880-125C8	60.50	6.53
CD14+ monocytes - treated with Candida, donor1	11868-125B5	30.67	5.38
CD14+ monocytes - treated with Candida, donor2	11878-125C6	33.27	6.34
CD14+ monocytes - treated with Candida, donor3	11888-125D7	28.84	4.44
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	34.96	4.76
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	27.74	2.99
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	56.84	7.08
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	41.64	2.75
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	40.26	6.11
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	32.73	5.24
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	39.00	2.69
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	41.35	4.88
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	53.02	6.31
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	36.56	2.20
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	42.62	1.76
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	43.00	4.83
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	35.57	3.14
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	39.03	3.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	54.97	5.82
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	31.12	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	42.19	3.94
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	58.46	5.10
CD14+CD16+ Monocytes, donor1	11789-124B7	49.91	3.05
CD14+CD16+ Monocytes, donor2	11801-124D1	51.05	4.39
CD14+CD16+ Monocytes, donor3	11912-125G4	55.67	4.55
CD14+CD16- Monocytes, donor1	11788-124B6	69.61	6.85
CD14+CD16- Monocytes, donor2	11799-124C8	58.86	4.19
CD14+CD16- Monocytes, donor3	11910-125G2	81.16	4.01
CD14-CD16+ Monocytes, donor1	11790-124B8	46.95	3.32
CD14-CD16+ Monocytes, donor2	11800-124C9	50.72	2.42
CD14-CD16+ Monocytes, donor3	11911-125G3	50.74	4.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	77.23	4.06
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	87.46	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	85.95	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	104.48	2.13
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	101.85	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	78.62	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	79.22	1.57
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	97.55	1.32
CD19+ B Cells, donor1	11544-120B5	85.48	10.68
CD19+ B Cells, donor2	11624-122B4	82.70	7.25
CD19+ B Cells, donor3	11705-123B4	69.67	6.06
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	158.79	7.68
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	130.63	7.99
CD34+ Progenitors, donor1	11545-120B6	65.26	4.02
CD34+ Progenitors, donor2	11625-122B5	58.43	6.74
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	74.02	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	84.56	4.51
CD4+ T Cells, donor1	11225-116C1	108.90	4.28
CD4+ T Cells, donor2	11306-117C1	75.93	6.12
CD4+ T Cells, donor3	11382-118B5	66.18	10.98
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	91.12	2.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	84.67	0.90
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	93.42	2.01
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	125.63	7.59
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	148.89	7.73
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	125.26	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	81.36	2.75
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	49.14	2.03
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	54.97	1.61
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	91.00	10.31
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	104.82	3.84
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	120.11	5.72
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	89.39	2.11
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	52.98	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	51.79	1.34
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	135.70	4.89
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	156.50	2.68
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	86.07	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	87.34	2.04
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	72.35	3.25
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	78.39	2.52
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	99.60	13.15
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	100.08	6.07
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	106.77	7.84
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	114.31	4.95
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	84.93	3.69
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	100.50	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	118.53	3.05
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	141.10	3.68
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	120.12	3.08
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	108.15	1.43
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	95.56	2.77
CD8+ T Cells, donor1	11226-116C2	108.70	18.01
CD8+ T Cells, donor2	11307-117C2	62.32	9.76
CD8+ T Cells, donor3	11383-118B6	81.81	12.62
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	39.00	1.38
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	30.19	1.68
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	35.02	2.19
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	43.53	1.80
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	34.08	1.44
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	36.61	1.82
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	33.68	1.74
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	27.37	1.05
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	36.82	0.94
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	38.04	1.51
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	35.15	1.74
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	36.24	1.60
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	33.71	2.19
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	28.69	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	29.83	3.73
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	32.05	2.16
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	32.22	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	36.30	1.89
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	40.56	1.58
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	39.98	2.46
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	33.34	2.56
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	39.39	1.15
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	36.65	1.97
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	42.36	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	55.40	4.01
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	51.76	4.20
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	57.10	3.01
Cardiac Myocyte, donor1	11525-119I4	18.28	1.83
Cardiac Myocyte, donor2	11605-120I3	38.54	2.96
Cardiac Myocyte, donor3	11686-122I3	61.03	3.16
Chondrocyte - de diff, donor1	11261-116G1	75.92	2.08
Chondrocyte - de diff, donor2	11338-117F6	36.96	3.20
Chondrocyte - de diff, donor3	11410-118E6	38.80	1.82
Chondrocyte - re diff, donor2	11339-117F7	92.21	3.58
Chondrocyte - re diff, donor3	11411-118E7	41.65	2.83
Ciliary Epithelial Cells, donor1	11242-116D9	108.33	3.44
Ciliary Epithelial Cells, donor2	11323-117D9	60.50	2.99
Ciliary Epithelial Cells, donor3	11399-118D4	71.51	3.98
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	80.42	4.40
Corneal Epithelial Cells, donor1	11526-119I5	7.47	0.44
Corneal Epithelial Cells, donor2	11606-120I4	12.51	0.00
Corneal Epithelial Cells, donor3	11687-122I4	11.76	1.02
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	69.01	1.16
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	62.45	1.58
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	79.37	6.90
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	41.79	0.97
Dendritic Cells - plasmacytoid, donor1	11228-116C4	62.52	2.05
Dendritic Cells - plasmacytoid, donor2	11309-117C4	68.55	1.96
Dendritic Cells - plasmacytoid, donor3	11385-118B8	65.82	2.42
Endothelial Cells - Aortic, donor0	11207-116A1	28.52	1.67
Endothelial Cells - Aortic, donor1	11263-116G3	24.64	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	22.62	2.26
Endothelial Cells - Aortic, donor3	11412-118E8	12.19	1.18
Endothelial Cells - Artery, donor1	11264-116G4	16.29	1.16
Endothelial Cells - Artery, donor2	11341-117F9	29.88	0.71
Endothelial Cells - Artery, donor3	11413-118E9	19.81	0.70
Endothelial Cells - Lymphatic, donor1	11236-116D3	42.11	1.77
Endothelial Cells - Lymphatic, donor2	11317-117D3	47.77	3.35
Endothelial Cells - Lymphatic, donor3	11393-118C7	63.99	4.23
Endothelial Cells - Microvascular, donor1	11265-116G5	20.50	1.78
Endothelial Cells - Microvascular, donor2	11342-117G1	27.07	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	13.33	0.85
Endothelial Cells - Thoracic, donor1	11266-116G6	50.01	4.00
Endothelial Cells - Thoracic, donor2	11343-117G2	18.34	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	76.91	3.11
Endothelial Cells - Umbilical vein, donor2	11324-117E1	51.27	2.39
Endothelial Cells - Umbilical vein, donor3	11400-118D5	44.45	2.44
Endothelial Cells - Vein, donor1	11267-116G7	13.65	2.28
Endothelial Cells - Vein, donor2	11344-117G3	24.45	0.00
Endothelial Cells - Vein, donor3	11416-118F3	27.01	2.67
Eosinophils, donor1	12244-129H3	60.99	0.00
Eosinophils, donor2	12245-129H4	108.92	19.80
Eosinophils, donor3	12246-129H5	35.67	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	8.06	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	0.00	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	50.90	4.11
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	24.20	1.20
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	45.61	1.19
Fibroblast - Aortic Adventitial, donor1	11245-116E3	68.89	3.03
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	61.55	2.59
Fibroblast - Aortic Adventitial, donor2	11326-117E3	47.25	2.43
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	39.00	3.69
Fibroblast - Aortic Adventitial, donor3	11401-118D6	58.13	1.99
Fibroblast - Cardiac, donor1	11268-116G8	36.74	1.81
Fibroblast - Cardiac, donor2	11345-117G4	34.11	2.27
Fibroblast - Cardiac, donor3	11417-118F4	21.45	1.89
Fibroblast - Cardiac, donor4	11452-119A3	80.63	2.12
Fibroblast - Cardiac, donor5	11456-119A7	53.93	1.52
Fibroblast - Cardiac, donor6	11460-119B2	53.06	2.43
Fibroblast - Choroid Plexus, donor1	11492-119E7	31.76	0.67
Fibroblast - Choroid Plexus, donor2	11572-120E6	36.67	1.29
Fibroblast - Choroid Plexus, donor3	11653-122E6	49.80	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	24.45	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	63.09	2.04
Fibroblast - Dermal, donor1	11269-116G9	45.78	1.17
Fibroblast - Dermal, donor2	11346-117G5	28.30	2.36
Fibroblast - Dermal, donor3	11418-118F5	46.78	0.97
Fibroblast - Dermal, donor4	11450-119A1	68.39	2.94
Fibroblast - Dermal, donor5	11454-119A5	72.05	3.66
Fibroblast - Dermal, donor6	11458-119A9	76.99	3.74
Fibroblast - Gingival, donor1	11237-116D4	88.91	2.92
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	78.60	1.83
Fibroblast - Gingival, donor2	11318-117D4	68.79	1.05
Fibroblast - Gingival, donor3	11394-118C8	67.87	1.55
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	50.91	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	45.99	0.53
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	77.64	4.68
Fibroblast - Gingival, donor6 (control)	11922-125H5	71.26	2.03
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	24.70	0.71
Fibroblast - Gingival, donor7 (control)	11924-125H7	84.24	3.07
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	81.54	3.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	79.09	4.28
Fibroblast - Gingival, donor9 (control)	11927-125I1	69.26	2.64
Fibroblast - Lung, donor1	11270-116H1	9.52	0.00
Fibroblast - Lung, donor2	11347-117G6	95.50	4.48
Fibroblast - Lung, donor3	11419-118F6	42.42	1.48
Fibroblast - Lymphatic, donor1	11506-119G3	32.49	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	9.79	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	3.08	0.00
Fibroblast - Mammary, donor1	11540-120B1	33.29	1.22
Fibroblast - Mammary, donor2	11620-122A9	7.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	29.78	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	93.69	3.30
Fibroblast - Periodontal Ligament, donor2	11319-117D5	95.10	1.67
Fibroblast - Periodontal Ligament, donor3	11395-118C9	100.98	2.14
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	53.05	2.67
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	60.21	1.35
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	44.30	2.32
Fibroblast - Pulmonary Artery, donor1	11250-116E8	59.69	2.65
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	26.41	0.61
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	11.36	1.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	35.58	1.19
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	50.60	4.56
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	67.32	1.07
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	78.83	3.35
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	44.53	1.81
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	85.07	3.56
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	46.82	1.77
Fibroblast - skin normal, donor1	11553-120C5	73.84	2.63
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	87.82	2.21
Fibroblast - skin normal, donor2	11561-120D4	80.67	1.51
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	59.84	2.42
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	76.30	2.07
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	74.19	1.54
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	42.37	3.28
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	72.54	3.73
Fibroblast - skin walker warburg, donor1	11554-120C6	60.56	2.19
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	55.04	2.67
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	354.56	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	63.62	2.61
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	56.51	3.81
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	58.29	2.08
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	52.38	4.09
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	61.24	7.66
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	82.31	8.93
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	108.40	8.27
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	126.57	3.58
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	86.76	5.71
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	89.95	6.14
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	108.64	3.70
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	92.95	4.57
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	118.52	10.61
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	81.40	9.75
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	76.35	7.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	70.65	6.72
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	60.71	5.33
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	61.88	6.09
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	46.76	6.30
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	50.66	3.88
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	62.91	3.99
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	47.21	2.40
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	54.07	3.25
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	75.66	5.09
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	59.21	3.13
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	53.03	3.63
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	80.07	4.07
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	90.00	6.65
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	85.74	2.91
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	86.07	4.78
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	65.73	3.98
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	83.61	4.58
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	87.59	5.51
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	54.46	2.48
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	73.90	3.57
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	62.87	2.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	37.91	1.76
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	69.37	3.32
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	53.49	3.89
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	45.22	3.21
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	58.75	3.22
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	48.24	2.69
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	58.69	1.22
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	60.84	4.08
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	49.84	2.42
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	47.97	1.68
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	58.70	3.33
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	54.82	2.41
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	49.73	2.91
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	53.24	4.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	54.49	3.80
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	47.19	2.77
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	46.71	2.41
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	58.51	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	50.52	3.03
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	39.95	1.21
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	73.45	2.29
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	122.22	15.53
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	72.42	9.24
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	112.93	15.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	71.35	11.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	74.31	5.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	118.07	9.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	116.32	19.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	99.80	9.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	85.04	4.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	76.51	12.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	87.23	8.14
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	110.77	7.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	89.97	6.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	91.17	6.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	72.89	7.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	79.69	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	106.24	4.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	75.40	5.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	89.79	6.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	91.06	5.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	53.57	2.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	113.51	6.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	93.61	8.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	91.59	5.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	100.10	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	86.88	6.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	79.86	6.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	65.55	3.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	95.55	4.62
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	97.22	9.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	104.36	4.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	90.60	3.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	88.11	3.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	100.72	4.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	92.53	5.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	96.20	9.87
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	95.62	4.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	89.27	2.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	94.80	4.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	72.05	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	46.56	5.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	72.30	3.40
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	21.68	3.42
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	30.35	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	16.87	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	39.65	0.95
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	22.14	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	34.23	3.13
Hep-2 cells mock treated, biol_rep2	11899-125E9	40.68	2.03
Hep-2 cells mock treated, biol_rep3	11900-125F1	36.17	3.87
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	36.18	3.28
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	37.18	3.44
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	38.75	4.09
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	33.00	1.49
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	33.45	3.60
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	33.64	2.56
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	19.59	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	7.36	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	15.86	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	13.40	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	5.81	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	35.67	2.27
Hepatocyte, donor1	11523-119I2	85.95	1.21
Hepatocyte, donor2	11603-120I1	66.79	7.54
Hepatocyte, donor3	11684-122I1	57.67	2.45
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	45.69	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	92.81	2.62
Iris Pigment Epithelial Cells, donor1	11530-119I9	57.35	1.65
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	38.21	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	33.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	135.42	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	13.84	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	25.03	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	35.60	11.87
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	7.69	7.69
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	13.71	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	34.11	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	13.34	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	14.52	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	21.18	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	9.98	2.22
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	20.95	10.48
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	22.05	1.26
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	17.01	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	14.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	18.74	1.94
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	6.44	3.22
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	15.48	1.63
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	13.43	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	21.70	1.61
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	12.00	1.85
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	11.80	1.89
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	12.70	2.72
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	29.06	3.23
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	12.70	2.54
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	16.43
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	21.04	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	21.87	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	79.02	15.80
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	19.99	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	19.91	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	19.14	2.47
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	19.32	5.27
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	15.72	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	22.95	2.09
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	35.41	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	25.94	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	30.52	1.74
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	22.50	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	20.91	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	24.54	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	23.55	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	14.25	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	21.17	2.76
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	27.23	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	6.21
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	20.09	0.00
Keratinocyte - epidermal, donor1	11272-116H3	39.17	1.22
Keratinocyte - epidermal, donor2	11349-117G8	14.06	0.00
Keratinocyte - epidermal, donor3	11421-118F8	46.38	0.76
Keratinocyte - oral, donor1	11251-116E9	80.14	1.59
Keratocytes, donor1	11527-119I6	20.63	1.72
Keratocytes, donor2	11607-120I5	11.72	0.00
Keratocytes, donor3	11688-122I5	43.67	1.19
Krukenberg tumor cell line:HSKTC	10687-109F3	90.11	6.59
Lens Epithelial Cells, donor1	11529-119I8	56.09	2.16
Lens Epithelial Cells, donor2	11609-120I7	91.57	3.46
Lens Epithelial Cells, donor3	11690-122I7	71.95	3.23
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	28.22	1.42
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	15.91	1.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	33.84	1.73
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	22.58	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	16.07	0.95
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	12.08	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	30.37	3.28
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	9.61	1.01
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	15.90	0.70
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	25.71	1.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	25.59	1.74
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	6.30	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	25.43	1.39
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	20.27	1.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	15.25	0.41
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	30.80	0.92
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	10.29	1.25
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	14.09	0.91
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	25.34	1.32
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	10.25	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	10.46	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	36.37	3.39
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	21.01	1.08
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	19.53	0.61
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	16.59	1.56
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	28.48	1.68
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	15.19	0.60
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	21.32	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	22.20	1.13
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	10.50	0.53
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	27.62	1.45
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	14.55	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	12.27	0.62
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	34.80	1.48
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	22.98	2.47
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	10.72	0.82
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	38.60	2.89
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	32.87	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	27.57	1.12
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	27.73	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	10.67	0.97
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	7.62	0.62
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	21.13	1.43
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	17.31	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	7.06	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	21.78	1.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	6.66	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	14.62	0.90
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	31.72	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	23.78	3.07
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	14.10	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	22.43	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	15.47	2.11
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	14.01	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	25.76	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	20.22	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	26.92	1.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	25.01	1.16
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	27.46	2.70
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	29.81	1.49
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	22.08	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	30.35	1.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	28.65	3.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	31.58	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	28.01	1.87
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	28.53	1.32
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	30.06	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	19.57	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	31.65	1.04
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	30.83	1.40
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	21.64	2.06
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	30.48	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	32.58	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	34.86	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	21.21	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	22.50	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	23.03	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	20.72	1.15
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	19.25	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	21.33	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	19.88	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	25.14	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	26.89	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	18.95	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	25.84	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	15.41	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	20.99	1.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	33.79	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	18.49	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	19.59	1.03
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	30.59	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	16.16	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	26.30	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	30.24	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	12.69	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	16.81	1.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	32.71	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	32.19	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	34.04	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	42.34	1.88
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	28.66	1.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	20.28	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	25.82	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	28.06	2.23
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	25.81	1.96
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	19.79	1.32
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	22.83	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	31.50	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	26.84	1.68
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	26.94	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	25.46	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	22.79	1.52
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	28.36	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	22.26	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	18.84	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	13.83	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	28.50	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	28.92	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	18.14	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	19.01	0.95
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	23.46	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	17.24	1.15
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	25.20	1.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	23.34	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	21.56	2.27
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	19.14	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	21.93	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	21.29	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	25.09	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	24.75	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	25.66	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	22.23	1.21
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	19.27	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	16.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	19.95	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	22.24	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	21.34	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	24.05	1.34
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	26.78	1.04
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	19.89	2.65
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	18.71	0.00
Macrophage - monocyte derived, donor1	11232-116C8	60.85	2.05
Macrophage - monocyte derived, donor2	11313-117C8	53.40	1.10
Macrophage - monocyte derived, donor3	11389-118C3	48.63	1.18
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	52.57	3.19
Mallassez-derived cells, donor2	11929-125I3	71.15	4.12
Mallassez-derived cells, donor3	11930-125I4	72.83	4.03
Mammary Epithelial Cell, donor1	11273-116H4	93.17	4.09
Mammary Epithelial Cell, donor2	11350-117G9	73.55	4.34
Mammary Epithelial Cell, donor3	11422-118F9	22.20	0.50
Mast cell - stimulated, donor1	11487-119E2	131.52	4.75
Mast cell, donor1	11563-120D6	75.27	2.05
Mast cell, donor2	11565-120D8	76.97	3.86
Mast cell, donor3	11566-120D9	82.17	3.38
Mast cell, donor4	11567-120E1	82.62	1.95
Mast cell, expanded and stimulated, donor5	11940-126A5	88.71	2.33
Mast cell, expanded and stimulated, donor8	11942-126A7	72.38	2.33
Mast cell, expanded, donor5	11939-126A4	76.06	1.03
Mast cell, expanded, donor8	11941-126A6	73.81	2.34
Melanocyte - dark, donor1	11502-119F8	60.00	2.89
Melanocyte - dark, donor2	11582-120F7	48.80	1.38
Melanocyte - dark, donor3	11663-122F7	114.02	2.54
Melanocyte - light, donor1	11274-116H5	25.86	1.18
Melanocyte - light, donor2	11351-117H1	14.33	1.36
Melanocyte - light, donor3	11423-118G1	5.20	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	61.85	2.60
Melanocyte, donor2 (MC+2)	12739-135I3	52.17	0.81
Melanocyte, donor3 (MC+3)	12837-137B2	70.45	1.34
Meningeal Cells, donor1	11493-119E8	35.36	1.24
Meningeal Cells, donor2	11573-120E7	27.29	1.32
Meningeal Cells, donor3	11654-122E7	82.64	2.85
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	88.68	2.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	63.50	2.82
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	7.88	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	7.85	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	41.62	1.44
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	65.86	1.69
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	47.75	1.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	20.22	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	18.26	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	11.87	0.82
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	79.09	2.35
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	15.61	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	92.10	3.42
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	14.54	1.19
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	9.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	15.37	1.28
Mesenchymal stem cells - adipose, donor0	11217-116B2	65.22	3.54
Mesenchymal stem cells - hepatic, donor0	11218-116B3	69.42	1.88
Mesenchymal stem cells - umbilical, donor0	11214-116A8	57.33	2.18
Mesothelial Cells, donor1	11247-116E5	51.71	1.33
Mesothelial Cells, donor2	12156-128G5	44.54	1.50
Mesothelial Cells, donor3	11402-118D7	43.00	1.59
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	17.55	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	57.14	2.46
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	58.89	2.65
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	27.66	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	62.61	3.41
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	47.29	0.62
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	11.58	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	49.05	3.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	60.05	1.86
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	48.16	1.83
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	46.72	1.58
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	33.63	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	53.57	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	13.16	1.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	38.84	2.12
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	29.47	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	36.96	0.89
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	10.06	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	34.62	2.26
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	45.87	1.19
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	10.50	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	42.60	1.38
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	40.81	1.26
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	31.39	1.02
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	36.04	2.15
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	38.90	1.56
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	31.98	2.19
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	29.91	1.01
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	23.20	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	32.07	2.17
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	45.88	2.06
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	7.63	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	31.72	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	34.02	2.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	9.60	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	33.54	2.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	80.84	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	10.19	2.04
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	34.60	1.75
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	14.35	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	11.53	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	34.71	2.23
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	36.88	1.39
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	11.05	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	35.90	1.03
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	22.32	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	10.65	0.71
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	37.31	1.40
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	24.52	0.83
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	13.40	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	30.77	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	37.15	1.25
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	36.94	2.77
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	35.85	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	24.18	1.66
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	32.91	1.30
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	25.74	1.29
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	8.89	1.27
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	32.56	1.87
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	46.70	3.59
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	22.60	1.27
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	34.08	0.96
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	35.60	2.43
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	19.72	1.14
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	38.07	2.27
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	31.71	1.23
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	20.20	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	37.64	2.06
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	45.84	2.31
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	58.52	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	36.03	3.28
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	45.20	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	48.12	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	45.67	1.31
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	32.61	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	49.82	1.58
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	49.36	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	46.94	0.75
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	35.16	1.86
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	46.94	2.15
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	23.58	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	37.01	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	45.11	3.11
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	56.65	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	15.46	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	30.30	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	52.70	1.26
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	42.22	2.72
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	23.52	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	37.25	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	33.23	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	91.36	11.42
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	61.99	6.52
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	52.28	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	100.39	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	68.29	5.17
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	45.47	2.61
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	33.37	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	27.13	1.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	57.99	2.66
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	67.03	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	31.28	1.36
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	152.52	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	27.62	1.26
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	43.23	2.32
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	30.54	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	44.99	1.47
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	155.89	22.27
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	32.26	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	44.66	2.44
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	32.42	2.04
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	27.76	1.31
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	43.01	2.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	32.36	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	20.41	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	64.32	1.31
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	27.48	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	42.33	2.12
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	22.50	1.41
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	28.04	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	35.03	0.96
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	51.04	2.07
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	169.41	7.59
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	41.44	1.34
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	33.02	2.12
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	34.18	1.42
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	40.35	1.72
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	108.33	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	33.32	1.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	36.07	2.25
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	36.51	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	26.93	1.86
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	52.22	2.27
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	25.09	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	16.56	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	53.37	4.07
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	29.98	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	25.26	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	38.69	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	27.56	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	38.11	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	45.31	2.43
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	32.53	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	153.29	10.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	35.97	1.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	28.33	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	21.49	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	24.53	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	63.48	7.94
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	131.51	10.12
Myoblast, donor1	11241-116D8	67.33	3.98
Myoblast, donor2	11322-117D8	68.66	1.53
Myoblast, donor3	11398-118D3	73.99	2.52
NK T cell leukemia cell line:KHYG-1	10777-110G3	44.95	0.88
Natural Killer Cells, donor1	11230-116C6	88.26	12.61
Natural Killer Cells, donor2	11311-117C6	52.47	12.06
Natural Killer Cells, donor3	11387-118C1	59.08	11.96
Neural stem cells, donor1	11275-116H6	187.28	8.35
Neural stem cells, donor2	11352-117H2	223.37	11.55
Neurons, donor1	11494-119E9	94.45	9.10
Neurons, donor2	11574-120E8	119.33	5.06
Neurons, donor3	11655-122E8	90.44	6.58
Neutrophils, donor1	11233-116C9	55.68	7.42
Neutrophils, donor2	11314-117C9	28.99	0.00
Neutrophils, donor3	11390-118C4	73.30	11.61
Nucleus Pulposus Cell, donor1	11252-116F1	72.31	1.90
Nucleus Pulposus Cell, donor2	11409-118E5	35.82	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	39.51	1.00
Olfactory epithelial cells, donor1	11933-125I7	43.64	0.96
Olfactory epithelial cells, donor2	11934-125I8	49.36	1.59
Olfactory epithelial cells, donor3	11935-125I9	45.17	1.36
Olfactory epithelial cells, donor4	11936-126A1	50.06	1.56
Oligodendrocyte - precursors, donor1	11496-119F2	84.86	2.41
Osteoblast - differentiated, donor1	11276-116H7	38.92	0.21
Osteoblast - differentiated, donor2	11353-117H3	10.29	1.14
Osteoblast - differentiated, donor3	11425-118G3	22.35	1.24
Osteoblast, donor1	11277-116H8	8.01	0.59
Osteoblast, donor2	11354-117H4	84.98	7.73
Osteoblast, donor3	11426-118G4	44.08	1.96
Pancreatic stromal cells, donor1	11249-116E7	64.52	2.02
Pericytes, donor1	11491-119E6	10.79	0.00
Pericytes, donor2	11571-120E5	7.02	0.45
Pericytes, donor3	11652-122E5	17.70	0.61
Perineurial Cells, donor1	11499-119F5	86.12	1.70
Perineurial Cells, donor2	11579-120F4	62.75	3.22
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	94.03	4.78
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	49.71	5.63
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	44.78	3.11
Placental Epithelial Cells, donor1	11278-116H9	24.87	1.20
Placental Epithelial Cells, donor2	11355-117H5	28.83	0.00
Placental Epithelial Cells, donor3	11427-118G5	12.96	1.57
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	32.91	0.00
Preadipocyte - breast, donor1	11467-119B9	63.78	2.44
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	52.60	1.31
Preadipocyte - breast, donor2	11328-117E5	42.10	2.25
Preadipocyte - omental, donor1	11468-119C1	66.60	2.34
Preadipocyte - omental, donor2	11329-117E6	58.49	0.00
Preadipocyte - omental, donor3	11403-118D8	59.59	1.58
Preadipocyte - perirenal, donor1	11469-119C2	24.61	2.95
Preadipocyte - subcutaneous, donor1	11279-116I1	24.57	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	84.47	4.07
Preadipocyte - subcutaneous, donor3	11428-118G6	55.17	3.58
Preadipocyte - visceral, donor1	11280-116I2	89.61	2.42
Preadipocyte - visceral, donor2	11357-117H7	63.97	2.30
Preadipocyte - visceral, donor3	11429-118G7	43.99	2.19
Prostate Epithelial Cells (polarized), donor1	11253-116F2	80.56	2.87
Prostate Epithelial Cells, donor2	11331-117E8	43.60	2.17
Prostate Epithelial Cells, donor3	11404-118D9	34.17	0.55
Prostate Stromal Cells, donor1	11254-116F3	63.33	1.82
Prostate Stromal Cells, donor2	11332-117E9	59.89	2.33
Prostate Stromal Cells, donor3	11405-118E1	43.07	0.83
Renal Cortical Epithelial Cells, donor1	11516-119H4	18.98	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	75.62	2.43
Renal Epithelial Cells, donor1	11517-119H5	17.25	1.52
Renal Epithelial Cells, donor2	11597-120H4	11.38	0.71
Renal Epithelial Cells, donor3	11678-122H4	101.21	3.18
Renal Glomerular Endothelial Cells, donor1	11514-119H2	7.49	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	14.55	0.94
Renal Glomerular Endothelial Cells, donor3	11675-122H1	46.40	2.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	6.65	0.67
Renal Mesangial Cells, donor1	11518-119H6	15.41	0.44
Renal Mesangial Cells, donor2	11598-120H5	11.29	0.63
Renal Mesangial Cells, donor3	11679-122H5	7.21	0.55
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	31.94	0.81
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	10.96	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	18.32	0.77
Retinal Pigment Epithelial Cells, donor0	11215-116A9	88.42	1.30
Retinal Pigment Epithelial Cells, donor1	11528-119I7	21.03	1.14
Retinal Pigment Epithelial Cells, donor2	11608-120I6	8.23	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	86.81	1.51
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	73.90	3.07
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	91.13	5.36
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	112.28	7.71
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	136.89	6.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	117.15	9.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	78.95	6.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	129.61	12.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	120.94	10.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	81.23	6.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	113.95	9.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	80.37	8.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	85.92	6.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	122.21	8.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	83.20	10.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	86.71	6.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	84.53	5.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	76.28	8.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	79.00	7.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	155.96	14.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	77.37	9.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	88.77	8.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	99.30	7.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	85.65	10.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	86.61	8.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	107.15	8.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	71.29	12.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	83.14	7.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	94.70	10.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	87.98	13.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	76.79	6.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	104.06	7.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	82.11	9.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	91.80	9.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	95.88	11.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	93.54	11.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	76.97	8.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	95.63	8.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	92.67	13.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	80.79	7.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	98.99	10.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	80.61	9.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	94.40	11.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	105.29	8.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	88.91	7.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	97.15	10.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	124.15	13.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	88.43	11.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	102.71	9.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	77.67	9.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	90.69	10.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	236.23	20.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	80.92	6.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	101.27	11.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	90.25	8.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	103.64	10.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	95.99	7.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	87.94	7.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	94.95	11.42
Schwann Cells, donor1	11498-119F4	15.80	0.56
Schwann Cells, donor2	11578-120F3	51.04	3.40
Schwann Cells, donor3	11659-122F3	49.73	1.10
Sebocyte, donor1	11220-116B5	23.01	3.29
Sebocyte, donor2	11301-117B5	14.25	1.38
Sebocyte, donor3	11378-118B1	11.75	0.62
Sertoli Cells, donor1	11255-116F4	114.31	1.66
Sertoli Cells, donor2	11333-117F1	56.49	5.65
Skeletal Muscle Cells, donor1	11281-116I3	54.63	2.29
Skeletal Muscle Cells, donor2	11358-117H8	11.57	1.45
Skeletal Muscle Cells, donor3	11430-118G8	26.75	3.34
Skeletal Muscle Cells, donor4	11451-119A2	61.89	3.93
Skeletal Muscle Cells, donor5	11455-119A6	63.62	2.97
Skeletal Muscle Cells, donor6	11459-119B1	67.10	2.62
Skeletal Muscle Satellite Cells, donor1	11240-116D7	109.50	3.02
Skeletal Muscle Satellite Cells, donor2	11321-117D7	78.19	1.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	74.61	2.48
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	51.06	1.77
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	23.16	2.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	16.92	0.55
Skin - palm, donor1	10286-104F7	45.66	5.37
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	20.33	0.72
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	260.91	17.99
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	27.65	1.69
Small Airway Epithelial Cells, donor1	11256-116F5	60.89	3.75
Small Airway Epithelial Cells, donor2	11334-117F2	38.40	2.95
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	162.60	8.03
Small Airway Epithelial Cells, donor3	11406-118E2	39.42	1.87
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	42.28	2.47
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	51.58	2.45
Smooth Muscle Cells - Aortic, donor0	11210-116A4	54.67	2.35
Smooth Muscle Cells - Aortic, donor1	11283-116I5	19.45	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	22.84	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	65.67	2.32
Smooth Muscle Cells - Bladder, donor1	11519-119H7	39.03	2.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	34.47	1.60
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	60.95	0.89
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	75.15	6.02
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	64.79	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	73.83	2.07
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	46.84	2.42
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	8.13	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	28.92	0.91
Smooth Muscle Cells - Carotid, donor1	11285-116I7	40.66	1.26
Smooth Muscle Cells - Carotid, donor2	11362-117I3	18.36	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	23.36	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	70.05	3.10
Smooth Muscle Cells - Colonic, donor2	11320-117D6	56.82	3.44
Smooth Muscle Cells - Colonic, donor3	11396-118D1	56.36	2.52
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	18.87	1.55
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	20.48	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	32.87	1.20
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	17.75	0.68
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	79.00	2.51
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	84.14	2.31
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	44.37	2.28
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	19.93	2.42
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	79.74	3.71
Smooth Muscle Cells - Prostate, donor1	11257-116F6	86.55	3.46
Smooth Muscle Cells - Prostate, donor2	11335-117F3	58.35	2.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	41.35	0.76
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	56.54	2.11
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	26.26	2.25
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	11.63	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	57.20	0.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	45.44	3.03
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	32.59	1.25
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	5.60	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	90.47	3.33
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	31.30	2.34
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	24.47	1.58
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	25.24	1.02
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	13.73	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	75.46	2.79
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	64.18	2.51
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	8.57	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	22.02	0.98
Smooth Muscle Cells - Uterine, donor1	11258-116F7	71.59	2.43
Smooth Muscle Cells - Uterine, donor3	11466-119B8	50.03	1.17
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	39.07	2.53
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	38.61	2.91
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	50.21	1.86
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	58.57	3.59
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	49.40	4.54
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	61.84	2.36
Smooth muscle cells - airway, control, donor1	11966-126D4	46.22	2.03
Smooth muscle cells - airway, control, donor2	11967-126D5	42.73	1.60
Smooth muscle cells - airway, control, donor3	11968-126D6	26.75	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	37.59	0.92
Synoviocyte, donor1	11291-117A4	65.65	3.20
Synoviocyte, donor2	11368-117I9	37.21	1.34
Synoviocyte, donor3	11440-118H9	41.11	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	21.80	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	11.89	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	21.77	0.93
Tracheal Epithelial Cells, donor1	11292-117A5	38.14	1.00
Tracheal Epithelial Cells, donor2	11369-118A1	11.60	1.16
Tracheal Epithelial Cells, donor3	11441-118I1	11.45	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	75.78	3.20
Urethra, donor2	10319-105A4	62.94	3.60
Urothelial Cells, donor1	11520-119H8	10.89	0.80
Urothelial Cells, donor2	11600-120H7	7.61	0.00
Urothelial Cells, donor3	11681-122H7	7.11	0.00
Urothelial cells, donor0	11216-116B1	77.79	0.89
Whole blood (ribopure), donor090309, donation1	12179-129A1	72.96	3.56
Whole blood (ribopure), donor090309, donation2	12180-129A2	72.91	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	34.23	1.37
Whole blood (ribopure), donor090325, donation1	12176-128I7	54.75	2.07
Whole blood (ribopure), donor090325, donation2	12177-128I8	73.21	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	62.47	2.08
Whole blood (ribopure), donor090612, donation2	12183-129A5	76.18	4.59
Whole blood (ribopure), donor090612, donation3	12184-129A6	22.82	3.65
Wilms' tumor cell line:G-401	10809-111A8	85.37	3.70
Wilms' tumor cell line:HFWT	10597-108E3	46.64	2.64
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	37.43	2.79
achilles tendon, donor2	10292-104G4	26.86	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	98.41	2.04
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	70.12	3.02
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	108.02	2.14
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	92.25	2.99
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	23.05	1.41
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	83.32	3.60
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	54.44	1.91
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	62.13	2.64
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	82.49	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	64.46	2.33
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	55.57	2.21
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	58.51	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	91.79	3.49
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	94.76	3.11
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	97.61	3.51
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	79.94	3.25
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	76.08	4.11
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	35.91	1.84
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	98.14	2.13
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	86.74	2.73
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	102.06	2.89
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	33.86	1.11
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	84.05	3.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	68.75	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	79.10	7.91
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	97.26	6.11
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	63.73	9.37
adenocarcinoma cell line:IM95m	10796-110I4	104.56	6.12
adipose tissue, adult, pool1	10010-101C1	55.38	2.79
adipose, donor1	10184-103D4	208.76	7.62
adipose, donor2	10185-103D5	75.02	4.87
adipose, donor3	10186-103D6	79.24	3.54
adipose, donor4	10187-103D7	71.07	12.13
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	67.23	3.16
adrenal gland, adult, pool1	10081-102A9	47.29	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	70.17	3.20
alveolar cell carcinoma cell line:SW 1573	10708-109H6	78.96	3.22
amniotic membrane cells, donor1	12235-129G3	57.73	3.48
amniotic membrane cells, donor2	12236-129G4	65.25	0.34
amniotic membrane cells, donor3	12237-129G5	50.08	0.00
amygdala - adult, donor10196	10167-103B5	184.98	9.49
amygdala, adult, donor10252	10151-102I7	117.81	7.10
amygdala, newborn, donor10223	10360-105E9	110.06	6.46
anaplastic carcinoma cell line:8305C	10428-106D5	136.24	6.11
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	42.14	2.87
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	152.65	4.01
aorta, adult, pool1	10052-101G7	43.93	1.57
appendix, adult	10189-103D9	87.33	3.49
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	125.19	13.76
artery, adult	10190-103E1	72.01	5.43
astrocytoma cell line:TM-31	10425-106D2	234.11	7.53
b cell line:RPMI1788	10427-106D4	84.16	2.23
basal cell carcinoma cell line:TE 354.T	10702-109G9	60.48	2.50
bile duct carcinoma cell line:HuCCT1	10432-106D9	78.99	3.27
bile duct carcinoma cell line:TFK-1	10496-107C1	64.61	0.84
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	54.81	1.68
bladder, adult, pool1	10011-101C2	66.60	1.85
blood, adult, pool1	10053-101G8	31.00	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	49.67	1.71
bone marrow, adult	10192-103E3	87.05	6.07
brain, adult, donor1	10084-102B3	60.48	2.05
brain, adult, pool1	10012-101C3	160.02	5.23
brain, fetal, pool1	10085-102B4	80.14	0.00
breast carcinoma cell line:MCF7	10482-107A5	53.52	2.64
breast carcinoma cell line:MDA-MB-453	10419-106C5	99.11	2.37
breast, adult, donor1	10080-102A8	24.62	2.53
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	57.55	1.40
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	136.06	6.49
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	64.46	3.68
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	82.07	3.15
carcinoid cell line:NCI-H1770	10703-109H1	38.55	2.82
carcinoid cell line:NCI-H727	10735-110B6	92.65	5.14
carcinoid cell line:SK-PN-DW	10719-109I8	53.56	1.27
carcinosarcoma cell line:JHUCS-1	10642-109A3	108.33	5.59
caudate nucleus - adult, donor10196	10177-103C6	151.97	4.61
caudate nucleus, adult, donor10252	10164-103B2	126.00	2.84
caudate nucleus, adult, donor10258	10379-105H1	197.15	6.11
caudate nucleus, newborn, donor10223	10354-105E3	105.11	6.23
cerebellum - adult, donor10196	10173-103C2	265.11	17.48
cerebellum, adult, donor10252	10166-103B4	139.42	7.90
cerebellum, adult, pool1	10083-102B2	107.62	5.17
cerebellum, newborn, donor10223	10357-105E6	156.09	5.81
cerebral meninges, adult	10188-103D8	153.81	6.56
cerebrospinal fluid, donor2	10294-104G6	53.35	2.92
cervical cancer cell line:D98-AH2	10552-107I3	96.33	2.44
cervical cancer cell line:ME-180	10553-107I4	78.38	2.49
cervix, adult, pool1	10013-101C4	90.82	3.57
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	98.79	5.43
chondrosarcoma cell line:SW 1353	10700-109G7	28.74	0.00
choriocarcinoma cell line:BeWo	10423-106C9	78.67	4.47
choriocarcinoma cell line:SCH	10785-110H2	49.04	1.60
choriocarcinoma cell line:T3M-3	10618-108G6	27.99	2.37
chorionic membrane cells, donor1	12238-129G6	44.16	1.99
chorionic membrane cells, donor2	12239-129G7	72.49	2.19
chorionic membrane cells, donor3	12240-129G8	48.90	2.20
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	39.38	2.02
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	49.37	1.92
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	77.51	7.60
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	74.22	4.37
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	84.66	4.84
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	79.61	5.09
chronic myelogenous leukemia cell line:K562	10454-106G4	93.05	5.01
chronic myelogenous leukemia cell line:KU812	10409-106B4	93.56	3.91
clear cell carcinoma cell line:JHOC-5	10638-108I8	34.29	2.29
clear cell carcinoma cell line:TEN	10636-108I6	40.60	1.04
colon carcinoma cell line:CACO-2	10513-107D9	69.74	4.03
colon carcinoma cell line:COLO-320	10420-106C6	164.20	2.28
colon, adult, donor1	10082-102B1	47.60	0.00
colon, adult, pool1	10014-101C5	86.13	2.82
colon, fetal, donor1	10070-101I7	53.77	0.62
common myeloid progenitor CMP, donor1	12130-128D6	155.84	18.33
common myeloid progenitor CMP, donor2	12134-128E1	75.11	25.04
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	133.85	5.95
cord blood derived cell line:COBL-a 24h infection	10453-106G3	82.71	3.92
cord blood derived cell line:COBL-a untreated	10449-106F8	87.00	3.95
corpus callosum, adult, pool1	10042-101F6	108.35	2.87
cruciate ligament, donor2	10295-104G7	37.28	4.05
diaphragm, fetal, donor1	10069-101I6	68.22	5.62
diencephalon, adult	10193-103E4	107.75	4.08
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	67.96	1.38
ductal cell carcinoma cell line:KLM-1	10438-106E6	108.99	3.08
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	72.46	3.61
ductus deferens, adult	10196-103E7	96.68	2.99
duodenum, fetal, donor1, tech_rep1	10071-101I8	59.05	2.88
duodenum, fetal, donor1, tech_rep2	10071-101I8	113.29	5.15
dura mater, adult, donor1	10041-101F5	95.97	1.90
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	88.16	8.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	75.23	6.30
embryonic pancreas cell line:1B2C6	10604-108F1	63.51	3.70
embryonic pancreas cell line:1C3D3	10605-108F2	56.91	2.72
embryonic pancreas cell line:1C3IKEI	10606-108F3	67.92	2.16
embryonic pancreas cell line:2C6	10603-108E9	61.73	2.63
endometrial carcinoma cell line:OMC-2	10497-107C2	104.92	7.37
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	103.49	4.53
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	63.20	3.70
epidermoid carcinoma cell line:A431	10426-106D3	41.02	1.45
epidermoid carcinoma cell line:Ca Ski	10431-106D8	45.53	3.08
epididymis, adult	10197-103E8	89.59	2.72
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	73.45	1.42
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	34.21	1.57
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	54.65	3.80
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	57.18	4.23
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	60.61	3.81
esophagus, adult, pool1	10015-101C6	68.70	1.59
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	127.49	3.13
eye - muscle inferior rectus, donor1	10272-104E2	45.88	4.83
eye - muscle lateral, donor2	10298-104H1	79.96	6.31
eye - muscle medial, donor2	10299-104H2	68.46	13.39
eye - muscle superior, donor2	10297-104G9	49.30	3.44
eye - vitreous humor, donor1	10268-104D7	21.86	2.91
eye, fetal, donor1	10054-101G9	77.54	2.29
fibrosarcoma cell line:HT-1080	10758-110E2	54.24	2.95
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	37.99	2.37
frontal lobe, adult, pool1	10040-101F4	234.18	7.79
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	143.52	4.50
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	128.56	4.66
gall bladder, adult	10198-103E9	55.29	1.45
gamma delta positive T cells, donor1	11937-126A2	81.07	4.83
gamma delta positive T cells, donor2	11938-126A3	66.48	7.84
gastric adenocarcinoma cell line:MKN1	10614-108G2	70.97	5.07
gastric adenocarcinoma cell line:MKN45	10612-108F9	53.00	1.55
gastric cancer cell line:AZ521	10549-107H9	141.17	7.54
gastric cancer cell line:GSS	10560-108A2	46.68	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	74.25	6.17
giant cell carcinoma cell line:LU65	10487-107B1	43.26	2.18
giant cell carcinoma cell line:Lu99B	10433-106E1	63.12	1.96
glassy cell carcinoma cell line:HOKUG	10688-109F4	31.43	1.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	76.31	4.43
glioblastoma cell line:A172, tech_rep2	10444-106F3	79.91	4.07
glioblastoma cell line:T98G	10485-107A8	66.78	2.65
glioma cell line:GI-1	10413-106B8	51.84	1.76
globus pallidus - adult, donor10196	10175-103C4	133.39	4.37
globus pallidus, adult, donor10252	10161-103A8	126.44	4.64
globus pallidus, adult, donor10258	10367-105F7	95.84	5.48
globus pallidus, newborn, donor10223	10364-105F4	97.52	3.20
granulocyte macrophage progenitor, donor1	12131-128D7	159.06	19.58
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	0.00
granulosa cell tumor cell line:KGN	10624-108H3	55.68	2.24
hIPS +CCl2, biol_rep1	14383-156B9	101.46	9.64
hIPS +CCl2, biol_rep2	14384-156C1	107.46	5.49
hIPS +CCl2, biol_rep3	14385-156C2	90.17	7.73
hIPS, biol_rep1	14380-156B6	129.36	23.00
hIPS, biol_rep2	14381-156B7	91.91	12.35
hIPS, biol_rep3	14382-156B8	163.31	13.24
hairy cell leukemia cell line:Mo	10712-109I1	46.26	1.72
heart - mitral valve, adult	10205-103F7	83.41	6.88
heart - pulmonic valve, adult	10206-103F8	97.01	3.40
heart - tricuspid valve, adult	10207-103F9	67.44	4.16
heart, adult, diseased post-infarction, donor1	10050-101G5	47.95	2.65
heart, adult, diseased, donor1	10051-101G6	52.80	3.41
heart, adult, pool1	10016-101C7	178.92	11.50
heart, fetal, pool1	10046-101G1	103.60	4.42
hepatic mesenchymal tumor cell line:LI90	10778-110G4	64.48	2.47
hepatoblastoma cell line:HuH-6	10633-108I3	28.54	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	65.19	4.75
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	75.25	5.83
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	73.57	6.57
hepatoma cell line:Li-7	10484-107A7	82.97	3.56
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	70.75	2.91
hippocampus - adult, donor10196	10169-103B7	163.71	13.25
hippocampus, adult, donor10252	10153-102I9	125.32	5.71
hippocampus, adult, donor10258	10374-105G5	197.19	7.97
hippocampus, newborn, donor10223	10363-105F3	93.76	3.88
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	145.87	10.99
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	81.68	6.48
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	95.72	6.60
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	97.55	4.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	90.63	3.87
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	128.31	6.45
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	117.37	5.55
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	104.05	4.52
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	108.44	2.50
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	119.34	6.39
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	90.97	4.34
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	129.27	12.12
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	76.21	6.26
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	77.13	9.33
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	115.20	13.09
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	112.45	4.20
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	114.69	4.80
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	127.94	6.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	76.11	2.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	89.12	4.55
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	88.33	2.82
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	86.88	6.37
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	78.09	5.23
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	100.74	3.89
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	82.95	6.10
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	75.60	5.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	117.19	7.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	86.96	4.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	89.64	4.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	96.54	3.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	86.36	3.62
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	75.05	5.31
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	87.99	3.08
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	76.44	4.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	105.25	6.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	96.11	6.05
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	85.25	6.04
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	104.73	8.02
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	91.71	6.83
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	93.52	4.58
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	549.80	39.04
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	131.72	1.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	101.25	4.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	92.64	5.79
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	94.31	5.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	85.92	5.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	138.13	6.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	79.47	4.58
immature langerhans cells, donor1	11904-125F5	76.76	8.48
immature langerhans cells, donor2	11905-125F6	49.11	5.54
insula, adult, pool1	10039-101F3	202.89	7.29
keratoacanthoma cell line:HKA-1	10791-110H8	23.41	0.33
kidney, adult, pool1	10017-101C8	148.99	9.21
kidney, fetal, pool1	10045-101F9	70.67	2.12
large cell lung carcinoma cell line:IA-LM	10509-107D5	81.80	4.83
large cell lung carcinoma cell line:NCI-H460	10839-111E2	42.58	2.21
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	49.18	3.12
left atrium, adult, donor1	10079-102A7	63.20	5.45
left ventricle, adult, donor1	10078-102A6	76.35	9.10
leiomyoblastoma cell line:G-402	10721-110A1	77.71	4.10
leiomyoma cell line:10964C	10569-108B2	30.18	1.08
leiomyoma cell line:15242A	10570-108B3	34.24	1.63
leiomyoma cell line:15425	10571-108B4	50.51	2.19
leiomyosarcoma cell line:Hs 5.T	10722-110A2	63.49	12.70
lens epithelial cell line:SRA 01/04	10647-109A8	62.73	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	61.98	9.80
liposarcoma cell line:KMLS-1	10782-110G8	61.86	3.12
liposarcoma cell line:SW 872	10726-110A6	50.69	2.80
liver, adult, pool1	10018-101C9	72.44	2.59
liver, fetal, pool1	10086-102B5	14.11	0.94
locus coeruleus - adult, donor10196	10182-103D2	101.64	6.56
locus coeruleus, adult, donor10252	10165-103B3	101.50	4.43
locus coeruleus, adult, donor10258	10375-105G6	98.18	5.64
locus coeruleus, newborn, donor10223	10362-105F2	106.84	7.57
lung adenocarcinoma cell line:A549	10499-107C4	51.48	1.38
lung adenocarcinoma cell line:PC-14	10408-106B3	65.49	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	64.06	3.30
lung, adult, pool1	10019-101D1	74.42	2.24
lung, fetal, donor1	10068-101I5	205.21	8.85
lung, right lower lobe, adult, donor1	10075-102A3	56.82	1.83
lymph node, adult, donor1	10077-102A5	35.98	0.95
lymphangiectasia cell line:DS-1	10727-110A7	48.22	2.41
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	52.37	1.66
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	77.30	3.40
mature adipocyte, donor1	12231-129F8	75.92	2.22
mature adipocyte, donor2	12232-129F9	79.90	1.04
mature adipocyte, donor3	12233-129G1	79.42	1.90
mature adipocyte, donor4	12234-129G2	91.86	1.84
maxillary sinus tumor cell line:HSQ-89	10414-106B9	104.12	3.34
medial frontal gyrus - adult, donor10196	10170-103B8	169.20	7.90
medial frontal gyrus, adult, donor10252	10150-102I6	126.71	6.44
medial frontal gyrus, adult, donor10258	10368-105F8	192.52	8.26
medial frontal gyrus, newborn, donor10223	10352-105E1	213.24	8.10
medial temporal gyrus - adult, donor10196	10183-103D3	179.38	6.92
medial temporal gyrus, adult, donor10252	10156-103A3	117.36	5.73
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	186.85	11.56
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	760.74	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	128.50	7.90
medulla oblongata - adult, donor10196	10174-103C3	109.03	7.14
medulla oblongata, adult, donor10252	10155-103A2	111.92	4.80
medulla oblongata, adult, pool1	10038-101F2	115.83	4.82
medulla oblongata, newborn, donor10223	10361-105F1	70.48	3.47
medulloblastoma cell line:D283 Med	10838-111E1	128.20	9.30
medulloblastoma cell line:ONS-76	10759-110E3	39.25	2.93
melanoma cell line:COLO 679	10514-107E1	84.67	3.16
melanoma cell line:G-361	10465-106H6	41.26	0.81
meningioma cell line:HKBMM	10691-109F7	41.25	1.09
merkel cell carcinoma cell line:MKL-1	10843-111E6	144.51	9.69
merkel cell carcinoma cell line:MS-1	10844-111E7	109.91	5.18
mesenchymal precursor cell - adipose, donor1	11747-123G1	59.69	2.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	49.26	1.82
mesenchymal precursor cell - adipose, donor3	11749-123G3	50.52	2.90
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	44.11	1.26
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	47.56	0.96
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	60.38	2.78
mesenchymal precursor cell - cardiac, donor1	11752-123G6	44.45	1.89
mesenchymal precursor cell - cardiac, donor2	11753-123G7	47.04	1.84
mesenchymal precursor cell - cardiac, donor3	11754-123G8	51.07	2.12
mesenchymal precursor cell - cardiac, donor4	11755-123G9	60.50	2.84
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	61.17	2.70
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	48.42	2.63
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	67.39	2.91
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	60.74	1.75
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	52.67	1.43
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	44.57	2.88
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	44.59	1.55
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	43.32	2.74
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	96.08	3.36
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	54.99	2.54
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	48.93	2.01
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	49.70	1.10
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	54.37	4.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	78.73	5.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	43.84	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	43.74	1.53
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	53.66	1.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	40.67	2.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	39.77	1.88
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	43.66	1.69
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	43.62	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	38.92	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	47.59	2.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	52.21	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	47.35	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	75.53	2.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	40.28	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	49.13	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	44.24	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	62.89	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	30.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	56.19	2.27
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	49.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	52.24	1.60
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	44.98	2.45
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	54.81	1.55
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	48.27	4.20
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	47.69	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	47.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	53.96	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	49.96	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	27.05
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	50.04	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	46.22	3.45
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	45.13	8.60
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	23.95	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	48.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	31.38	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	29.39	1.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	27.71	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	40.83	2.49
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	25.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	33.11	3.55
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	23.11	7.70
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	53.01	2.07
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	47.50	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	44.86	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	43.89	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	42.72	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	15.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	19.01	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	50.98	4.86
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	72.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	41.18	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	50.60	0.79
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	32.45	1.30
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	24.45	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	51.84	1.55
mesothelioma cell line:ACC-MESO-1	10493-107B7	68.75	2.36
mesothelioma cell line:ACC-MESO-4	10494-107B8	38.69	1.62
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	85.47	12.82
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	56.31	4.11
mesothelioma cell line:Mero-25	10850-111F4	50.38	5.67
mesothelioma cell line:Mero-41	10851-111F5	39.60	1.22
mesothelioma cell line:Mero-48a	10852-111F6	36.54	0.89
mesothelioma cell line:Mero-82	10853-111F7	60.18	6.31
mesothelioma cell line:Mero-83	10854-111F8	85.28	6.30
mesothelioma cell line:Mero-84	10855-111F9	15.17	0.51
mesothelioma cell line:Mero-95	10856-111G1	53.42	3.93
mesothelioma cell line:NCI-H2052	10847-111F1	48.53	2.82
mesothelioma cell line:NCI-H226	10846-111E9	35.84	2.53
mesothelioma cell line:NCI-H2452	10848-111F2	56.54	1.54
mesothelioma cell line:NCI-H28	10845-111E8	44.02	1.78
mesothelioma cell line:No36	10857-111G2	42.41	2.61
mesothelioma cell line:ONE58	10858-111G3	28.72	1.08
migratory langerhans cells, donor1	11901-125F2	58.92	2.30
migratory langerhans cells, donor2	11902-125F3	58.00	0.73
migratory langerhans cells, donor3	11903-125F4	72.33	1.62
mixed mullerian tumor cell line:HTMMT	10689-109F5	48.32	1.63
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	13.99	1.70
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	49.30	2.53
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	41.29	2.28
myelodysplastic syndrome cell line:SKM-1	10772-110F7	87.59	1.66
myeloma cell line:PCM6	10474-106I6	57.92	1.19
myxofibrosarcoma cell line:MFH-ino	10600-108E6	69.50	6.59
myxofibrosarcoma cell line:NMFH-1	10684-109E9	52.37	3.14
nasal epithelial cells, donor1, tech_rep1	12226-129F3	40.45	1.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	41.26	1.18
nasal epithelial cells, donor2	12227-129F4	54.09	3.86
neuroblastoma cell line:CHP-134	10508-107D4	187.73	9.43
neuroblastoma cell line:NB-1	10539-107G8	170.62	17.59
neuroblastoma cell line:NBsusSR	10607-108F4	101.86	6.54
neuroblastoma cell line:NH-12	10555-107I6	161.57	9.69
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	70.93	1.90
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	66.52	0.79
neuroectodermal tumor cell line:TASK1	10774-110F9	52.73	1.21
neuroepithelioma cell line:SK-N-MC	10728-110A8	55.95	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	63.35	2.66
neutrophil PMN, donor1	12133-128D9	14.87	0.00
neutrophil PMN, donor2	12137-128E4	119.53	13.28
neutrophil PMN, donor3	12141-128E8	85.24	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	135.97	5.92
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	79.25	1.60
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	51.94	1.28
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	72.79	3.15
nucleus accumbens, adult, pool1	10037-101F1	183.92	6.47
occipital cortex - adult, donor10196	10172-103C1	226.64	14.42
occipital cortex, adult, donor10252	10163-103B1	123.72	6.71
occipital cortex, newborn, donor10223	10355-105E4	138.66	8.73
occipital lobe, adult, donor1	10076-102A4	142.22	7.61
occipital lobe, fetal, donor1	10073-102A1	172.93	12.01
occipital pole, adult, pool1	10036-101E9	97.21	2.68
olfactory region, adult	10195-103E6	140.23	5.73
optic nerve, donor1	10277-104E7	92.05	10.01
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	81.10	3.19
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	66.08	1.65
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	43.01	1.35
oral squamous cell carcinoma cell line:SAS	10544-107H4	51.98	2.77
osteoclastoma cell line:Hs 706.T	10704-109H2	55.56	3.23
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	103.71	3.74
osteosarcoma cell line:HS-Os-1	10558-107I9	50.47	3.39
ovary, adult, pool1	10020-101D2	78.09	3.58
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	70.94	4.58
pancreas, adult, donor1	10049-101G4	65.84	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	57.30	3.35
papillary adenocarcinoma cell line:8505C	10437-106E5	58.60	2.73
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	123.03	3.97
paracentral gyrus, adult, pool1	10035-101E8	182.31	5.40
parietal cortex, adult, donor10258	10373-105G4	155.61	5.14
parietal lobe - adult, donor10196	10171-103B9	172.11	11.29
parietal lobe, adult, donor10252	10157-103A4	123.42	4.85
parietal lobe, adult, pool1	10034-101E7	153.06	5.55
parietal lobe, fetal, donor1	10072-101I9	195.91	6.79
parietal lobe, newborn, donor10223	10356-105E5	145.06	8.22
parotid gland, adult	10199-103F1	80.17	2.47
penis, adult	10200-103F2	58.01	2.15
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	26.40	0.56
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	65.85	1.02
pineal gland - adult, donor10196	10179-103C8	201.25	31.61
pineal gland, adult, donor10252	10160-103A7	266.50	22.50
pineal gland, adult, donor10258	10377-105G8	176.83	15.05
pituitary gland - adult, donor10196	10180-103C9	214.50	26.31
pituitary gland, adult, donor10252	10162-103A9	358.57	28.66
pituitary gland, adult, donor10258	10378-105G9	227.28	20.43
placenta, adult, pool1	10021-101D3	66.76	2.80
plasma cell leukemia cell line:ARH-77	10840-111E3	68.73	2.38
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	41.40	2.33
pons, adult, pool1	10033-101E6	173.43	6.89
postcentral gyrus, adult, pool1	10032-101E5	115.25	3.84
promyelocytes/myelocytes PMC, donor1	12132-128D8	60.65	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	44.06	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	11.74
prostate cancer cell line:DU145	10490-107B4	120.61	4.66
prostate cancer cell line:PC-3	10439-106E7	73.69	3.27
prostate, adult, pool1	10022-101D4	71.92	1.90
putamen, adult, donor10196	10176-103C5	214.35	7.55
putamen, adult, donor10252	10152-102I8	125.49	7.84
putamen, adult, donor10258, tech_rep1	10372-105G3	116.93	3.28
putamen, adult, donor10258, tech_rep2	10372-105G3	151.01	3.62
putamen, newborn, donor10223	10365-105F5	115.45	7.50
rectal cancer cell line:TT1TKB	10469-106I1	43.35	1.16
rectum, fetal, donor1	10067-101I4	76.50	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	41.98	0.85
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	74.97	1.24
retina, adult, pool1	10030-101E3	89.66	1.79
retinoblastoma cell line:Y79	10475-106I7	131.98	7.01
rhabdomyosarcoma cell line:KYM-1	10787-110H4	93.56	4.79
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	81.27	3.37
sacrococcigeal teratoma cell line:HTST	10695-109G2	45.47	1.52
salivary acinar cells, donor1	11771-123I7	47.75	2.91
salivary acinar cells, donor2	11772-123I8	48.74	1.38
salivary acinar cells, donor3	11773-123I9	47.67	3.31
salivary gland, adult, pool1	10093-102C3	100.66	2.86
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	78.58	1.26
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	82.17	2.12
seminal vesicle, adult	10201-103F3	104.23	2.12
serous adenocarcinoma cell line:JHOS-2	10639-108I9	51.01	3.16
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	24.16	1.26
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	56.20	2.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	63.67	2.15
signet ring carcinoma cell line:Kato III	10436-106E4	58.25	1.55
signet ring carcinoma cell line:NUGC-4	10483-107A6	85.29	4.77
skeletal muscle - soleus muscle, donor1	10282-104F3	68.81	4.97
skeletal muscle, adult, pool1	10023-101D5	79.64	2.16
skeletal muscle, fetal, donor1	10066-101I3	33.17	0.00
skin, adult, donor1	10074-102A2	54.28	0.00
skin, fetal, donor1	10065-101I2	74.48	1.89
small cell cervical cancer cell line:HCSC-1	10800-110I8	139.41	4.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	136.17	7.56
small cell lung carcinoma cell line:DMS 144	10841-111E4	65.92	1.35
small cell lung carcinoma cell line:LK-2	10541-107H1	142.74	6.76
small cell lung carcinoma cell line:NCI-H82	10842-111E5	24.93	1.61
small cell lung carcinoma cell line:WA-hT	10562-108A4	95.23	5.88
small intestine, adult, pool1	10024-101D6	114.19	4.54
small intestine, fetal, donor1	10064-101I1	72.73	2.21
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	57.96	4.62
smooth muscle, adult, pool1	10048-101G3	56.34	2.07
somatostatinoma cell line:QGP-1	10781-110G7	73.71	3.22
spinal cord - adult, donor10196	10181-103D1	85.80	6.65
spinal cord, adult, donor10252	10159-103A6	129.72	7.49
spinal cord, adult, donor10258	10369-105F9	125.91	10.38
spinal cord, fetal, donor1	10056-101H2	100.62	7.32
spinal cord, newborn, donor10223	10359-105E8	128.12	3.21
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	61.68	1.49
spleen, adult, pool1	10025-101D7	69.16	1.87
spleen, fetal, pool1	10044-101F8	44.73	1.99
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	44.20	1.35
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	120.19	5.70
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	54.51	2.80
squamous cell carcinoma cell line:T3M-5	10616-108G4	74.67	5.47
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	90.83	2.81
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	33.04	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	60.08	5.50
stomach, fetal, donor1	10062-101H8	91.85	4.27
submaxillary gland, adult	10202-103F4	90.01	3.99
substantia nigra - adult, donor10196	10178-103C7	162.82	108.55
substantia nigra, adult, donor10252	10158-103A5	100.32	3.95
substantia nigra, adult, donor10258	10371-105G2	199.66	10.86
substantia nigra, newborn, donor10223	10358-105E7	88.32	4.24
synovial sarcoma cell line:HS-SY-II	10441-106E9	99.04	4.59
temporal lobe, adult, pool1	10031-101E4	92.48	2.88
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	128.21	11.40
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	143.73	4.40
tenocyte, donor1	11763-123H8	58.30	2.44
tenocyte, donor2	11765-123I1	31.28	1.14
tenocyte, donor3	11768-123I4	41.51	1.48
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	79.71	4.08
teratocarcinoma cell line:NCR-G1	10798-110I6	45.01	2.16
teratocarcinoma cell line:PA-1	10807-111A6	96.71	5.27
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	51.67	5.97
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	53.70	5.29
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	34.35	4.04
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	91.85	4.56
testis, adult, pool1	10026-101D8	73.12	3.65
testis, adult, pool2	10096-102C6	73.08	7.22
thalamus - adult, donor10196	10168-103B6	151.25	7.73
thalamus, adult, donor10252	10154-103A1	119.09	5.78
thalamus, adult, donor10258, tech_rep1	10370-105G1	214.01	10.78
thalamus, adult, donor10258, tech_rep2	10370-105G1	78.23	6.59
thalamus, newborn, donor10223	10366-105F6	115.06	8.63
throat, adult	10209-103G2	77.65	3.25
throat, fetal, donor1	10061-101H7	80.14	4.88
thymic carcinoma cell line:Ty-82	10803-111A2	128.38	5.56
thymus, adult, pool1	10027-101D9	78.44	1.79
thymus, fetal, pool1	10043-101F7	97.46	2.39
thyroid carcinoma cell line:KHM-5M	10776-110G2	38.82	2.26
thyroid carcinoma cell line:TCO-1	10783-110G9	59.79	2.10
thyroid, adult, pool1	10028-101E1	95.83	1.96
thyroid, fetal, donor1	10060-101H6	106.52	3.95
tongue epidermis (fungiform papillae), donor1	10288-104F9	89.31	3.08
tongue, adult	10203-103F5	82.56	2.33
tongue, fetal, donor1	10059-101H5	86.31	6.31
tonsil, adult, pool1	10047-101G2	71.93	1.10
trachea, adult, pool1	10029-101E2	78.85	1.64
trachea, fetal, donor1	10058-101H4	68.48	2.31
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	55.27	1.77
transitional-cell carcinoma cell line:5637	10418-106C4	63.73	2.84
transitional-cell carcinoma cell line:JMSU1	10492-107B6	62.52	3.45
tridermal teratoma cell line:HGRT	10694-109G1	43.76	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	62.73	2.20
umbilical cord, fetal, donor1	10057-101H3	41.73	6.26
uterus, adult, pool1	10100-102D1	98.96	4.78
uterus, fetal, donor1	10055-101H1	73.21	3.58
vagina, adult	10204-103F6	39.42	3.23
vein, adult	10191-103E2	46.69	1.32
xeroderma pigentosum b cell line:XPL 17	10563-108A5	40.06	0.53